3 of 20 unique stocks in common · Jaccard: 15%
A weighted portfolio overlap of 20.67% indicates a moderate overlap (a meaningful shared core). This means that out of every ₹100 you invest across these two schemes, approximately ₹20.67 is allocated to the exact same companies at the same relative proportions. The schemes share 3 common holdings.
The largest overlapping asset in their portfolios is HFCL, which commands a weight of 8.59% in quant Consumption Fund and 9.55% in quant Healthcare Fund. Holding both schemes increases your concentration in HFCL rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in quant Consumption | in quant Healthcare |
|---|---|---|
| HFCLTelecom - Services | 8.59% | 9.55% |
| Zydus WellnessFood Products | 7.13% | 8.74% |
| Aurobindo PharmaPharmaceuticals & Biotechnology | 6.61% | 4.95% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on May 2026). Equity holdings only, ISIN-verified. Not investment advice.